Cardiovascular disease test kit LYOFIA®

cardiac troponin Ibloodserum

This device is intended to be used for the in vitro quantitative determination of High Sensitive Cardiac Troponin I (hs-cTnI) in human whole blood, serum or plasma. And it is for professional use only, not for self-testing of untrained individuals, nor for near-patient testing. Summary Troponin is composed of three subunits of troponin I, T, and C, which together with tropomyosin to regulate the interaction between actin and myosin by regulating the activity of Ca2+ on striated actin ATPase. After myocardial injury, cardiac troponin complexes are released into the blood. After 4 to 6 hours, the increase can be detected in the blood, and the elevated troponin I can remain in the blood for 6 to 10 days, providing longer detection period. Cardiac troponin I (cTnI) has high myocardial specificity and sensitivity, so it has become an ideal marker of myocardial infarction. This kit adopts a highly sensitive method to measure cTnI, namely high sensitive cardiac troponin I (hs-cTnI), which can detect the increase of cTnI in the blood at the early stage of myocardial injury (1-2 hours), and can detect cTnI in more than 50% of healthy population samples, and the coefficient of variation of the 99th percentile value is ≤10%. The current clinical methods for detecting cTnI include chemiluminescence, colloidal gold method, immunochromatography and so on. PRODUCT PARAMETER Linearity 9～50000pg/mL Certificate CE / NMPA Reference Interval ≤27 pg/mL